196 related articles for article (PubMed ID: 30680409)
1. [Early detection of Alzheimer's disease and approaches for prevention].
Jessen F
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Mar; 62(3):255-260. PubMed ID: 30680409
[TBL] [Abstract][Full Text] [Related]
2. Advances in the prevention of Alzheimer's disease and dementia.
Solomon A; Mangialasche F; Richard E; Andrieu S; Bennett DA; Breteler M; Fratiglioni L; Hooshmand B; Khachaturian AS; Schneider LS; Skoog I; Kivipelto M
J Intern Med; 2014 Mar; 275(3):229-50. PubMed ID: 24605807
[TBL] [Abstract][Full Text] [Related]
3. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
[TBL] [Abstract][Full Text] [Related]
4. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
[TBL] [Abstract][Full Text] [Related]
5. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
[TBL] [Abstract][Full Text] [Related]
6. Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies.
Lista S; Dubois B; Hampel H
J Nutr Health Aging; 2015 Feb; 19(2):154-63. PubMed ID: 25651440
[TBL] [Abstract][Full Text] [Related]
7. The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results.
de Mauléon A; Soto M; Kiyasova V; Delrieu J; Guignot I; Galtier S; Lilamand M; Cantet C; Lala F; Sastre N; Andrieu S; Pueyo M; Ousset PJ; Vellas B
J Prev Alzheimers Dis; 2017; 4(3):183-193. PubMed ID: 29182709
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
Gauthier S; Leuzy A; Racine E; Rosa-Neto P
Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
[TBL] [Abstract][Full Text] [Related]
9. Review of the Ethical Issues of a Biomarker-Based Diagnoses in the Early Stage of Alzheimer's Disease.
Vanderschaeghe G; Dierickx K; Vandenberghe R
J Bioeth Inq; 2018 Jun; 15(2):219-230. PubMed ID: 29532386
[TBL] [Abstract][Full Text] [Related]
10. CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.
Lista S; Garaci FG; Ewers M; Teipel S; Zetterberg H; Blennow K; Hampel H
Alzheimers Dement; 2014 May; 10(3):381-92. PubMed ID: 23850330
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Prevention Strategies Targeting Different Preclinical Stages of Alzheimer's Disease.
Zhou B
Curr Alzheimer Res; 2015; 12(6):504-6. PubMed ID: 26027809
[TBL] [Abstract][Full Text] [Related]
14. Association Between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals: A Longitudinal Descriptive Cohort Study.
Reijs BLR; Vos SJB; Soininen H; Lötjonen J; Koikkalainen J; Pikkarainen M; Hall A; Vanninen R; Liu Y; Herukka SK; Freund-Levi Y; Frisoni GB; Frölich L; Nobili F; Rikkert MO; Spiru L; Tsolaki M; Wallin ÅK; Scheltens P; Verhey F; Visser PJ
J Alzheimers Dis; 2017; 60(4):1387-1395. PubMed ID: 29036813
[TBL] [Abstract][Full Text] [Related]
15. Lifestyle Patterns as a Modifiable Risk Factor for Late-life Cognitive Decline: A Narrative Review Regarding Dementia Prevention.
Wajman JR; Mansur LL; Yassuda MS
Curr Aging Sci; 2018; 11(2):90-99. PubMed ID: 30280679
[TBL] [Abstract][Full Text] [Related]
16. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
[TBL] [Abstract][Full Text] [Related]
17. Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease.
Forlenza OV; Diniz BS; Teixeira AL; Stella F; Gattaz W
Braz J Psychiatry; 2013; 35(3):284-94. PubMed ID: 24142092
[TBL] [Abstract][Full Text] [Related]
18. Prediction and Early Detection of Alzheimer's Dementia: Professional Disclosure Practices and Ethical Attitudes.
Schweda M; Kögel A; Bartels C; Wiltfang J; Schneider A; Schicktanz S
J Alzheimers Dis; 2018; 62(1):145-155. PubMed ID: 29439325
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
